ID NUD10_HUMAN Reviewed; 164 AA. AC Q8NFP7; Q86VK1; Q86VR0; DT 05-JUL-2005, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2002, sequence version 1. DT 07-JUL-2009, entry version 56. DE RecName: Full=Diphosphoinositol polyphosphate phosphohydrolase 3-alpha; DE Short=DIPP-3-alpha; DE Short=DIPP3-alpha; DE Short=hDIPP3alpha; DE EC=3.6.1.52; DE AltName: Full=Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-alpha; DE EC=3.6.1.-; DE AltName: Full=Nucleoside diphosphate-linked moiety X motif 10; DE Short=Nudix motif 10; DE Short=hAps2; GN Name=NUDT10; Synonyms=APS2, DIPP3A; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], ENZYME ACTIVITY, BIOPHYSICOCHEMICAL RP PROPERTIES, AND TISSUE SPECIFICITY. RX MEDLINE=22194402; PubMed=12105228; DOI=10.1074/jbc.M205476200; RA Hidaka K., Caffrey J.J., Hua L., Zhang T., Falck J.R., Nickel G.C., RA Carrel L., Barnes L.D., Shears S.B.; RT "An adjacent pair of human NUDT genes on chromosome X are RT preferentially expressed in testis and encode two new isoforms of RT diphosphoinositol polyphosphate phosphohydrolase."; RL J. Biol. Chem. 277:32730-32738(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15772651; DOI=10.1038/nature03440; RA Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., RA Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., RA Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., RA Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S., RA Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., RA Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., RA Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., RA Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., RA Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., RA Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., RA Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., RA Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., RA Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., RA Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., RA Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., RA Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., RA Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., RA Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., RA Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., RA Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., RA Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., RA Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., RA Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S., RA Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., RA Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., RA Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., RA Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., RA de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., RA Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., RA Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., RA Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., RA Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., RA McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., RA Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., RA Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., RA Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., RA Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., RA Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., RA Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., RA Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., RA Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., RA Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., RA Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., RA Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., RA Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., RA Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., RA Williams G., Williams L., Williamson A., Williamson H., Wilming L., RA Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., RA Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., RA Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., RA Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., RA Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., RA Gibbs R.A., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence of the human X chromosome."; RL Nature 434:325-337(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP ENZYME ACTIVITY, SUBCELLULAR LOCATION, COFACTOR, BIOPHYSICOCHEMICAL RP PROPERTIES, AND TISSUE SPECIFICITY. RX MEDLINE=22325330; PubMed=12121577; DOI=10.1186/1472-2091-3-20; RA Leslie N.R., McLennan A.G., Safrany S.T.; RT "Cloning and characterisation of hAps1 and hAps2, human diadenosine RT polyphosphate-metabolising Nudix hydrolases."; RL BMC Biochem. 3:20-20(2002). RN [5] RP ENZYME ACTIVITY. RX MEDLINE=22344714; PubMed=12370170; DOI=10.1074/jbc.M209795200; RA Fisher D.I., Safrany S.T., Strike P., McLennan A.G., Cartwright J.L.; RT "Nudix hydrolases that degrade dinucleoside and diphosphoinositol RT polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) RT pyrophosphatase activity that generates the glycolytic activator RT ribose 1,5-bisphosphate."; RL J. Biol. Chem. 277:47313-47317(2002). RN [6] RP IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY. RA Colinge J., Superti-Furga G., Bennett K.L.; RL Submitted (OCT-2008) to UniProtKB. CC -!- FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in CC PP-InsP5 (diphosphoinositol pentakisphosphate), suggesting that it CC may play a role in signal transduction. Also able to catalyzes the CC hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A CC being the preferred substrates. The major reaction products are CC ADP and p4a from Ap6A and ADP and ATP from Ap5A. Also able to CC hydrolyze 5-phosphoribose 1-diphosphate. CC -!- CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O = CC myo-inositol polyphosphate + phosphate. CC -!- COFACTOR: Magnesium or manganese. Manganese may be the true CC cofactor in vivo. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.088 uM for PP-InsP5; CC KM=19 uM for Ap6A; CC KM=50 uM for Ap5A; CC pH dependence: CC Optimum pH is 8.5; CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- TISSUE SPECIFICITY: Mainly expressed in testis and, at lower level CC in brain. According to PubMed:12121577, it is widely expressed. CC -!- SIMILARITY: Belongs to the Nudix hydrolase family. DIPP subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF469196; AAM64113.1; -; mRNA. DR EMBL; AL158055; CAI40295.1; -; Genomic_DNA. DR EMBL; BC049383; AAH49383.1; -; mRNA. DR EMBL; BC050700; AAH50700.1; -; mRNA. DR IPI; IPI00549204; -. DR RefSeq; NP_694853.1; -. DR UniGene; Hs.375178; -. DR SMR; Q8NFP7; 8-146. DR IntAct; Q8NFP7; 1. DR PRIDE; Q8NFP7; -. DR Ensembl; ENSG00000122824; Homo sapiens. DR GeneID; 170685; -. DR KEGG; hsa:170685; -. DR UCSC; uc004dph.1; human. DR GeneCards; GC0XP051091; -. DR H-InvDB; HIX0028345; -. DR HGNC; HGNC:17621; NUDT10. DR MIM; 300527; gene. DR PharmGKB; PA31831; -. DR HOGENOM; Q8NFP7; -. DR HOVERGEN; Q8NFP7; -. DR OMA; Q8NFP7; DEWEDSK. DR BRENDA; 3.6.1.52; 247. DR NextBio; 89092; -. DR ArrayExpress; Q8NFP7; -. DR Bgee; Q8NFP7; -. DR CleanEx; HS_NUDT10; -. DR GermOnline; ENSG00000122824; Homo sapiens. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0008486; F:diphosphoinositol-polyphosphate diphosphata...; ISS:UniProtKB. DR GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-KW. DR GO; GO:0030145; F:manganese ion binding; IEA:UniProtKB-KW. DR InterPro; IPR000086; NUDIX_hydrolase_core. DR Gene3D; G3DSA:3.90.79.10; NUDIX_hydrolase; 1. DR Pfam; PF00293; NUDIX; 1. DR PROSITE; PS00893; NUDIX; 1. PE 1: Evidence at protein level; KW Complete proteome; Cytoplasm; Hydrolase; Magnesium; Manganese; KW Metal-binding. FT CHAIN 1 164 Diphosphoinositol polyphosphate FT phosphohydrolase 3-alpha. FT /FTId=PRO_0000057062. FT MOTIF 50 71 Nudix box. FT METAL 65 65 Magnesium or manganese (By similarity). FT METAL 69 69 Magnesium or manganese (By similarity). FT CONFLICT 90 90 K -> E (in Ref. 3; AAH50700). FT CONFLICT 135 135 V -> M (in Ref. 3; AAH49383). SQ SEQUENCE 164 AA; 18500 MW; 589F342E02B285A7 CRC64; MKCKPNQTRT YDPEGFKKRA ACLCFRSERE DEVLLVSSSR YPDRWIVPGG GMEPEEEPGG AAVREVYEEA GVKGKLGRLL GVFEQNQDPK HRTYVYVLTV TELLEDWEDS VSIGRKREWF KVEDAIKVLQ CHKPVHAEYL EKLKLGGSPT NGNSMAPSSP DSDP //